The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Rady Children’s oncologist Paula Aristizabal receives $4M to diversify clinical trials participation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Paula Aristizabal, a pediatric oncologist at Rady Children’s Hospital-San Diego and associate professor of pediatrics in pediatric hematology/oncology at the University of California San Diego and Moores Cancer Center, received a $4 million R01 research grant to expand a pilot program aimed at improving diverse participation in pediatric cancer clinical trials.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Imfinzi regimen reduced early disease recurrence in non-muscle-invasive bladder cancer, phase III trial POTOMAC shows

Exploratory analyses of the POTOMAC phase III trial showed adding one year of treatment with AstraZeneca’s Imfinzi (durvalumab) to BCG induction and maintenance therapy reduced the number of high-risk disease recurrences within the first year, with fewer BCG-unresponsive recurrences in patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer compared to BCG treatment alone.
Clinical Roundup

Perioperative Imfinzi + neoadjuvant EV improved EFS and OS in muscle-invasive bladder cancer, phase III VOLGA trial shows

High-level results from a planned interim analysis of the VOLGA phase III trial showed perioperative treatment with Imfinzi (durvalumab) in combination with neoadjuvant enfortumab vedotin demonstrated statistically significant and clinically meaningful improvements in event-free survival and overall survival in patients with muscle-invasive bladder cancer versus standard of care. 
In Brief

Northwestern Mutual to support childhood cancer survivors, siblings with $500,000 in college scholarships

Northwestern Mutual, through its Foundation, announced a class of scholars from its annual Childhood Cancer Scholarship Program for families affected by childhood cancer. The program provides scholarships to students affected by a diagnosis—either as survivors themselves or as siblings—enabling recipients to chase their dreams and transform their experience into purpose.
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account